The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference43 articles.
1. Life expectancy following radical amputation for carcinoma of the breast: a clinical and pathologic study of 218 cases;Sistrunk;Ann Surg,1922
2. Molecular portraits of human breast tumours;Perou;Nature,2000
3. Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer;Kos;NPJ Breast Cancer,2020
4. Diagnostic concordance among pathologists interpreting breast biopsy specimens;Elmore;J Am Med A,2015
5. Interobserver reproducibility of histopathological features in stage II breast cancer. An ECOG study;Gilchrist;Breast Cancer Res Treat,1985
Cited by 137 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PD-L1 expression and tumor-infiltrating lymphocytes: Correlations and prognostic values in Chinese triple-negative breast cancer patients with different molecular subtyping;Pathology - Research and Practice;2024-10
2. Upregulation of ZMAT3 is Associated with the Poor Prognosis of Breast Cancer;International Journal of General Medicine;2024-09
3. Germline polygenic risk scores are associated with immune gene expression signature and immune cell infiltration in breast cancer;The American Journal of Human Genetics;2024-09
4. Advances in siRNA Drug Delivery Strategies for Targeted TNBC Therapy;Bioengineering;2024-08-14
5. From Tumor Macroenvironment to Tumor Microenvironment: The Prognostic Role of the Immune System in Oral and Lung Squamous Cell Carcinoma;Cancers;2024-08-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3